We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $205.12, moving +1.37% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.53%. Meanwhile, the Dow lost 0.71%, and the Nasdaq, a tech-heavy index, lost 0.93%.
Prior to today's trading, shares of the hospital operator had gained 4.8% outpaced the Medical sector's gain of 3.64% and the S&P 500's gain of 1.13%.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 28, 2025. It is anticipated that the company will report an EPS of $3.33, marking a 13.65% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $5.24 billion, indicating a 2.22% growth compared to the corresponding quarter of the prior year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $15.82 per share and revenue of $21.16 billion, indicating changes of +33.16% and +2.38%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.17% lower within the past month. Tenet Healthcare currently has a Zacks Rank of #4 (Sell).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 12.79. This valuation marks a premium compared to its industry average Forward P/E of 10.12.
Also, we should mention that THC has a PEG ratio of 0.87. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. THC's industry had an average PEG ratio of 0.87 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 210, this industry ranks in the bottom 15% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
Tenet Healthcare (THC - Free Report) closed the most recent trading day at $205.12, moving +1.37% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.53%. Meanwhile, the Dow lost 0.71%, and the Nasdaq, a tech-heavy index, lost 0.93%.
Prior to today's trading, shares of the hospital operator had gained 4.8% outpaced the Medical sector's gain of 3.64% and the S&P 500's gain of 1.13%.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 28, 2025. It is anticipated that the company will report an EPS of $3.33, marking a 13.65% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $5.24 billion, indicating a 2.22% growth compared to the corresponding quarter of the prior year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $15.82 per share and revenue of $21.16 billion, indicating changes of +33.16% and +2.38%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.17% lower within the past month. Tenet Healthcare currently has a Zacks Rank of #4 (Sell).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 12.79. This valuation marks a premium compared to its industry average Forward P/E of 10.12.
Also, we should mention that THC has a PEG ratio of 0.87. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. THC's industry had an average PEG ratio of 0.87 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 210, this industry ranks in the bottom 15% of all industries, numbering over 250.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.